Hansen Medical Announces Common Stock Offering
17 4월 2009 - 5:02AM
Marketwired
Hansen Medical, Inc. (NASDAQ: HNSN) today announced that it intends
to offer shares of its common stock in a public offering. Piper
Jaffray & Co. will be the sole underwriter for the offering.
The offering is being made pursuant to a shelf registration
statement filed with the Securities and Exchange Commission on
March 5, 2008, which became effective on March 17, 2008. A
prospectus supplement relating to the offering will be filed with
the Securities and Exchange Commission.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any of the securities, nor shall
there be any sale of the securities in any state in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of such state. When
available, copies of the prospectus supplement relating to this
offering may be obtained by contacting Piper Jaffray & Co. at
800 Nicollet Mall, Suite 800, Minneapolis, MN 55402, or by
telephone at (800) 747-3924.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops
products and technology using robotics for the accurate
positioning, manipulation and control of catheters and
catheter-based technologies. The Sensei(TM) Robotic Catheter system
is a robotic navigation system that enables clinicians to place
mapping catheters in hard-to-reach anatomical locations within the
heart easily, accurately and with stability during complex cardiac
arrhythmia procedures. The Sensei system was cleared by the U.S.
Food and Drug Administration in May 2007 for manipulation and
control of certain mapping catheters in electrophysiology
procedures. Additional information can be found at
www.hansenmedical.com.
Forward-Looking Statements
This press release contains forward-looking statements
regarding, among other things, statements relating to expectations,
projections, estimates, goals, plans, objectives and future events.
We intend such forward-looking statements to be covered by the safe
harbor provisions for forward-looking statements contained in
Section 21E of the Exchange Act and the Private Securities
Litigation Reform Act of 1995. These statements are based on the
current estimates and assumptions of our management as of the date
of this press release and are subject to risks, uncertainties,
changes in circumstances, assumptions and other factors that may
cause actual results to differ materially from those indicated by
forward-looking statements. Factors that could cause actual results
to differ materially from those indicated by such forward-looking
statements are described in greater detail under the heading "Risk
Factors" contained in our periodic SEC filings, including our
Annual Report on Form 10-K filed with the SEC on March 16, 2009.
Given these uncertainties, you should not place undue reliance on
the forward-looking statements in this press release. We undertake
no obligation to revise or update information herein to reflect
events or circumstances in the future, even if new information
becomes available.
Investor Contacts: Steven Van Dick 650.404.5800 Email Contact
Lasse Glassen Financial Relations Board 213.486.6546 Email Contact
News Media Contact: Amy Cook 925.552.7893 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024